Hong Gao
Fudan University · Third Affiliated Hospital of Zhejiang Chinese Medical University · The Third Affiliated hospital of Zhejiang Chinese Medical University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hong Gao as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:04 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07405697 · Fecal Molecular Susceptibility-guided Hp Rescue TherapyShanghai Zhongshan Hospital · not yet recruiting · Helicobacter Pylori Infection · principal investigator
- N/ANCT07071428 · Acupuncture Treatment in Pediatric Patients With Tic Disorders: A Prospective, Single-Center, Randomized Controlled TrialThe Third Affiliated hospital of Zhejiang Chinese Medical University · completed · Tic Disorders · principal investigator
- N/ANCT05431010 · Efficacy on Walking Ability of Electroacupuncture Therapy in Elderly Patients With SarcopeniaThe Third Affiliated hospital of Zhejiang Chinese Medical University · recruiting · Sarcopenia · principal investigator
- Ph4NCT05250050 · Susceptibility-Guided Therapy for Helicobacter Pylori Infection TreatmentShanghai Zhongshan Hospital · withdrawn · Helicobacter Pylori Infection · principal investigator
- N/ANCT05187975 · Integrated Rehabilitation in Treating Post-stroke DepressionThe Third Affiliated hospital of Zhejiang Chinese Medical University · unknown · Post-stroke Depression · principal investigator
- N/ANCT05147077 · Integrated Rehabilitation in Treating Post-stroke AnxietyThe Third Affiliated hospital of Zhejiang Chinese Medical University · unknown · Post-stroke, Anxiety · principal investigator
- Ph3NCT03970694 · Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon CancerSun Yat-sen University · terminated · Colon Cancer · study chair
- N/ANCT03846726 · Treatment Strategy for Rectal Cancer Patients With Complete Clinical ResponseYuan-hong Gao · completed · Rectal Cancer, Organ Preservation · principal investigator
- Ph4NCT02935010 · Tailored Versus Empiric Therapy for Helicobacter Pylori TreatmentShanghai Jiao Tong University School of Medicine · completed · Helicobacter Pylori Infection · principal investigator
- Ph3NCT02512315 · A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal CarcinomaSun Yat-sen University · unknown · Nasopharyngeal Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 11 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:04 UTC. The ranking covers the 200 most relevant of 376 PubMed records, and a shared surname and initials can bring in a namesake. All 376 on PubMed
- Genomic responses in mouse models poorly mimic human inflammatory diseases.Proc Natl Acad Sci U S A · 20132,465 citationsRCR 77.5
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.N Engl J Med · 20211,334 citationsRCR 73.5
- A genomic storm in critically injured humans.J Exp Med · 2011919 citationsRCR 26.1
- 696 citationsRCR 17.7
- Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results.Nat Med · 2022547 citationsRCR 35.5
- REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.N Engl J Med · 2021527 citationsRCR 26.1
- Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study.Lancet Oncol · 2020426 citationsRCR 15.2
- 340 citationsRCR 17.9
- 267 citationsRCR 17.1
- Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma.Biomed Res Int · 2014257 citationsRCR 8.3